AI and GLP-1s: An update on the forces reshaping medical marketing

AI and GLP-1s.

As a healthcare reporter, we often get asked: ‘What are the top industry trends that brand and agency leaders are most focused on?’ 

And that’s our response: AI and GLP-1s.

Luckily for you, this week’s episode provides a taste of both.

Our feature interview this week is an in-person conversation between managing editor Jack O’Brien and Curtis Sparrer, principal and co-founder of Bospar PR.

Curtis flew in from San Francisco to preview the MM+M tracks at Haymarket Media’s second annual AI Deciphered conference on Thursday. 

(Please note, last minute tickets are still available!)

For Trends, pharma editor Lecia Bushak and editor-at-large Steve Madden get you up to speed on the week that was in GLP-1-land: from Pfizer muscling out Novo Nordisk for obesity drug developer Metsera, to the White House’s drug pricing deal with Novo and Eli Lilly.

Music: “Deep Reflection” by DP and Triple Scoop Music.

Check us out at: mmm-online.com

Follow us:

YouTube: @MMM-online

TikTok: @MMMnews

Instagram: @MMMnewsonline

Twitter/X: @MMMnews

LinkedIn: MM+M

To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Music: “Deep Reflection” by DP and Triple Scoop Music.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.